Ambuja Cements, Sun Pharma, Indus Towers and Eicher Motors are analysts’ top buy choices for today
On Friday, market tech analyst Mitessh Thakkar recommended these stocks for the short term.
Uncategorized
Spandana Sphoorty shares are down 70% from their peak, but no analyst has a ‘sell’ on the stock
Despite the 70% correction from its peak, none of the nine analysts who have coverage on Spandana Sphoorty have a “sell” rating on the stock. Five of them have a “buy” rating on the stock, while four have a “hold”…
Kalpataru Projects gains up to 3% on securing orders worth ₹2,038 crore
Kalpataru Projects Share Price | The company’s MD and CEO Manish Mohnot said that with the new orders, the firm’s year-to-date (YTD) order intake has surged to ₹19,361 crores.
Indus Towers Q3 results boost hopes of a larger dividend payout from the company
Out of the 24 analysts that have coverage on Indus Towers, 13 of them have a “buy” rating, six of them say “hold”, while five have a “sell” rating on the stock.
India presenting opportunity to buy on dips, top pick in Asia, says Standard Chartered Bank
India’s market correction presents an opportune moment for investors to capitalise on its growth story. With structural growth, external factors such as oil prices and dollar strength, and a focus on stabilising earnings, India remains the standout choice for investment…
Q3 Results LIVE: Torrent Pharma, IndiGo, Godrej Consumer and JSW Steel among key earnings today
Q3 Results live updates: Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here
Dr. Reddy’s shares fall 6% after Q3 results; analysts divided between ‘buy’ or ‘sell’
Dr. Reddy’s shares are the top losers on the Nifty 50 index today. Out of the 40 analysts that have coverage on Dr. Reddy’s, 15 of them have a ‘Buy’ rating, while 15 of them have a ‘Sell’ call. The…
UltraTech shares can see nearly 20% upside as analysts raise target price after Q3 results beat
UltraTech share price: Following Q3 earnings, UltraTech Cement remains top cement pick of several brokerages. They remain bullish on the stock given the firm’s strong cash flow generation and good leverage position. Check target prices here
Suryoday Small Finance Bank sees further deterioration in asset quality, slower loan growth in FY25
Suryoday Small Finance Bank’s Gross NPA for the quarter stood at 5.53% from 3.03% earlier, while Net NPA stood at 3.13% from 0.8% earlier. Provision Coverage Ratio fell to 44.7% from 74.3% in September.
BPCL shares are down 28% from peak but still expensive, says analyst
Brokerage firm Nuvama has highlighted concerns about BPCL’s weak refining margin environment and LPG under-recoveries, which are impacting its earnings. Additionally, the high capital expenditure cycle is weighing on the company’s return ratios, making the risk-reward scenario unfavorable.